Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Food Chem Toxicol ; 66: 173-84, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24491265

ABSTRACT

The potential health effects of meal and oil processed from seed of genetically modified (GM) canola plants (OECD unique identifier: DP-Ø73496-4; hereafter referred to as 73496 canola) containing an insert that expresses the GAT4621 protein conferring tolerance to nonselective herbicidal ingredient glyphosate were evaluated in a subchronic rodent feeding study. Sprague-Dawley rats (12/sex/group) were administered diets containing dehulled, defatted toasted canola meal (DH meal) and refined/bleached/deodorized canola oil (RBD oil) processed from seed of plants that were untreated (73496), sprayed in-field with glyphosate (73496GLY), the non-transgenic near-isogenic (091; control), or one of four commercially available non-GM reference canola varieties (45H72, 45H73, 46A65, 44A89). All diets were formulated as a modification of the standard laboratory chow PMI® Nutrition International, LLC Certified Rodent LabDiet® 5002 (PMI® 5002). DH canola meal and RBD canola oil replaced all commodity soybean fractions typically incorporated in PMI® 5002. No toxicologically significant differences were observed between the test and control groups in this study. The results reported herein support the conclusion that DH meal and RBD oil processed from seed of 73496 canola are as safe and nutritious as DH meal and RBD oil processed from seed of non-GM canola.


Subject(s)
Fatty Acids, Monounsaturated , Herbicides/pharmacology , Animals , Fatty Acids, Monounsaturated/chemistry , Female , Male , Organ Size/drug effects , Rapeseed Oil , Rats , Rats, Sprague-Dawley
2.
Food Chem Toxicol ; 53: 417-27, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23261672

ABSTRACT

The results from a subchronic feeding study conducted in Sprague­Dawley rats fed with diets containing grain from 4114 (OECD unique identifier: DP-ØØ4114-3) maize that was untreated (4114) or sprayed in field with glufosinate ammonium (4114GLU) in a design similar to previous studies are reported. The test material, 4114 maize, is a hybrid maize produced by transformation with a DNA construct encoding 4 different transgenic proteins for resistance to lepidopteran pests, coleopteran pests, and tolerance to the herbicidal active ingredient glufosinate ammonium. There were a total of 144 rats divided into 12 groups of 12 rats/sex/group. All experimental diets were formulated by Purina Mills, LLC (St. Louis, MO) in accordance with the standards of Purina Mills Labdiet® Certified Rodent LabDiet® 5002. The incorporation rate of maize grain in all diets was 32% (wt/wt). No biologically significant, treatment related differences in body weight, food consumption, clinical pathology parameters (hematology, blood chemistry, urinalysis, or organ weight) were observed in rats consuming the diets containing 4114 maize grain compared with rats fed conventional maize diets. A number of histologic observations were noted in this study but were background lesions and representative of what would be expected for rats of this age and strain. An independent panel of experts determined certain observations to be spontaneous and not related to the test diet. Accordingly, these results support the conclusion that 4114 maize grain is as safe and nutritious as conventional maize grain.


Subject(s)
Crops, Agricultural/toxicity , Diet , Plants, Genetically Modified/toxicity , Zea mays/toxicity , Animal Feed , Animals , Body Weight , Coleoptera , Crops, Agricultural/genetics , Female , Herbicides/pharmacology , Lepidoptera , Male , Organ Size , Plants, Genetically Modified/genetics , Rats , Rats, Sprague-Dawley , Urinalysis , Zea mays/genetics
3.
Food Chem Toxicol ; 49(12): 3192-205, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21920405

ABSTRACT

N-acetyl-l-aspartic acid (NAA) is a component of the mammalian central nervous system (CNS) that has also been identified in a number of foods. This paper reports the outcome of a reproductive toxicology study conducted with NAA in Sprague-Dawley rats. NAA was added to diets at target doses of 100, 250 and 500 mg/kg of body weight/day and administered for two consecutive generations. A carrier control group was administered diet with no added NAA and a comparative control group was given aspartate (ASP), the constituent amino acid of NAA, at a target dose of 500 mg/kg of body weight/day. The study evaluated OECD 416 reproductive performance variables and additional segments to assess potential developmental effects, neurobehavioural and ophthalmologic function, and the concentrations of NAA or ASP in brain and plasma. No biologically significant differences were observed in any reproductive response variables, neurobehavioural tests, ophthalmologic examinations, body weights, feed consumption, or organ weights. Further, no test substance related mortalities or adverse clinical, neurohistopathologic or histopathologic findings were observed. Under the conditions of this study, the highest target dose of NAA, 500 mg/kg of body weight/day, represents the no-observed-adverse-effect-level (NOAEL) for reproductive and systemic toxicity, and neurotoxicity for Sprague-Dawley rats.


Subject(s)
Aspartic Acid/analogs & derivatives , Toxicity Tests/methods , Animals , Aspartic Acid/administration & dosage , Aspartic Acid/toxicity , Body Weight/drug effects , Dose-Response Relationship, Drug , Female , Male , Neurotoxicity Syndromes/etiology , Neurotoxicity Syndromes/pathology , No-Observed-Adverse-Effect Level , Organ Size , Rats , Rats, Sprague-Dawley , Reproduction/drug effects
4.
Food Chem Toxicol ; 49(1): 155-65, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20946933

ABSTRACT

We investigated the systemic effects of subchronic dietary exposure to NAA in Sprague Dawley® rats. NAA was added to the diet at different concentrations to deliver target doses of 100, 250 and 500 mg/kg of body weight/day and was administered for 90 consecutive days. All rats (10/sex/group) survived until scheduled sacrifice. No diet-related differences in body weights, feed consumption and efficiency, clinical signs, or ophthalmologic findings were observed. No biologically significant differences or adverse effects were observed in functional observation battery (FOB) and motor activity evaluations, hematology, coagulation, clinical chemistry, urinalysis, organ weights, or gross pathology evaluations that were attributable to dietary exposure to NAA. Treatment-related increased incidence and degree of acinar cell hypertrophy in salivary glands was observed in both male and female rats in the high dose group. Because there was no evidence of injury or cytotoxicity to the salivary glands, this finding was not considered to be an adverse effect. Based on these results and the actual average doses consumed, the no-observed-adverse-effect-levels (NOAEL) for systemic toxicity from subchronic dietary exposure to NAA were 451.6 and 490.8 mg/kg of body weight/day for male and female Sprague Dawley® rats, respectively.


Subject(s)
Aspartic Acid/analogs & derivatives , Animals , Aspartic Acid/toxicity , Dose-Response Relationship, Drug , Female , Male , Motor Activity/drug effects , Organ Size/drug effects , Rats , Rats, Sprague-Dawley , Urinalysis
5.
Regul Toxicol Pharmacol ; 59(1): 53-63, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20868718

ABSTRACT

The 28-day repeat-dose oral and genetic toxicity of eicosapentaenoic acid triglyceride oil (EPA oil) produced from genetically modified Yarrowia lipolytica yeast were assessed. Groups of rats received 0 (olive oil), 940, 1880, or 2820 mg EPA oil/kg/day, or fish oil (sardine/anchovy source) by oral gavage. Lower total serum cholesterol was seen in all EPA and fish oil groups. Liver weights were increased in the medium and high-dose EPA (male only), and fish oil groups but were considered non-adverse physiologically adaptive responses. Increased thyroid follicular cell hypertrophy was observed in male high-dose EPA and fish oil groups, and was considered to be an adaptive response to high levels of polyunsaturated fatty acids. No adverse test substance-related effects were observed on body weight, nutritional, or other clinical or anatomic pathology parameters. The oil was not mutagenic in the in vitro Ames or mouse lymphoma assay, and was not clastogenic in the in vivo mouse micronucleus test. In conclusion, exposure for 28 days to EPA oil derived from yeast did not produce adverse effects at doses up to 2820 mg/kg/day and was not genotoxic. The safety profile of the EPA oil in these tests was comparable to a commercial fish oil.


Subject(s)
Arachidonic Acids/toxicity , Oils/toxicity , Triglycerides/toxicity , Yarrowia/metabolism , Administration, Oral , Animals , Arachidonic Acids/administration & dosage , Arachidonic Acids/biosynthesis , Body Weight/drug effects , Cell Line, Tumor , Cholesterol/blood , Eating/drug effects , Female , Fish Oils/toxicity , Hyperplasia , Liver/drug effects , Liver/pathology , Male , Mice , Mice, Inbred ICR , Micronucleus Tests , Mutagenicity Tests , Oils/administration & dosage , Oils/metabolism , Olive Oil , Plant Oils/toxicity , Rats , Rats, Sprague-Dawley , Risk Assessment , Thyroid Gland/drug effects , Thyroid Gland/pathology , Time Factors , Toxicity Tests , Triglycerides/administration & dosage , Triglycerides/biosynthesis , Yarrowia/genetics
6.
In Vitro Cell Dev Biol Anim ; 46(10): 811-9, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20927602

ABSTRACT

The role of cell authentication in biomedical science has received considerable attention, especially within the past decade. This quality control attribute is now beginning to be given the emphasis it deserves by granting agencies and by scientific journals. Short tandem repeat (STR) profiling, one of a few DNA profiling technologies now available, is being proposed for routine identification (authentication) of human cell lines, stem cells, and tissues. The advantage of this technique over methods such as isoenzyme analysis, karyotyping, human leukocyte antigen typing, etc., is that STR profiling can establish identity to the individual level, provided that the appropriate number and types of loci are evaluated. To best employ this technology, a standardized protocol and a data-driven, quality-controlled, and publically searchable database will be necessary. This public STR database (currently under development) will enable investigators to rapidly authenticate human-based cultures to the individual from whom the cells were sourced. Use of similar approaches for non-human animal cells will require developing other suitable loci sets. While implementing STR analysis on a more routine basis should significantly reduce the frequency of cell misidentification, additional technologies may be needed as part of an overall authentication paradigm. For instance, isoenzyme analysis, PCR-based DNA amplification, and sequence-based barcoding methods enable rapid confirmation of a cell line's species of origin while screening against cross-contaminations, especially when the cells present are not recognized by the species-specific STR method. Karyotyping may also be needed as a supporting tool during establishment of an STR database. Finally, good cell culture practices must always remain a major component of any effort to reduce the frequency of cell misidentification.


Subject(s)
Biometric Identification/methods , Biometric Identification/standards , Microsatellite Repeats/genetics , Cell Culture Techniques , Cell Line , Humans , Isoenzymes/genetics , Karyotyping , Quality Control , Stem Cells , United States
7.
Regul Toxicol Pharmacol ; 58(3): 490-500, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20804805

ABSTRACT

The safety of eicosapentaenoic acid (EPA) oil produced from genetically modified Yarrowia lipolytica yeast was evaluated following 90 days of exposure. Groups of rats received 0 (olive oil), 98, 488, or 976 mg EPA/kg/day, or GRAS fish oil or deionized water by oral gavage. Rats were evaluated for in-life, neurobehavioral, anatomic and clinical pathology parameters. Lower serum cholesterol (total and non-HDL) was observed in Medium and High EPA and fish oil groups. Lower HDL was observed in High EPA and fish oil males, only at early time points. Liver weights were increased in High EPA and Medium EPA (female only) groups with no associated clinical or microscopic pathology findings. Nasal lesions, attributed to oil in the nasal cavity, were observed in High and Medium EPA and fish oil groups. No other effects were attributed to test oil exposure. Exposure to EPA oil for 90 days produced no effects at 98 mg EPA/kg/day and no adverse effects at doses up to 976 mg EPA/kg/day. The safety profile of EPA oil was comparable to that of GRAS fish oil. These results support the use of EPA oil produced from yeast as a safe source for use in dietary supplements.


Subject(s)
Eicosapentaenoic Acid/toxicity , Oils/toxicity , Toxicity Tests/methods , Animals , Body Weight , Cholesterol/blood , Clinical Chemistry Tests , Fatty Acids/blood , Female , Fish Oils/toxicity , Food/toxicity , Hematologic Tests , Liver/drug effects , Male , Rats , Rats, Sprague-Dawley , Risk Assessment , Time Factors , Yeasts
8.
Inhal Toxicol ; 22(1): 56-68, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19538086

ABSTRACT

Since fibrous particles such as asbestos and some man-made fibers (MMF) have been known to produce carcinogenic or fibrogenic effects, disk-shaped potassium octatitanate (POT) particles (trade name: Terracess TF) were manufactured as nonfibrous particles. A 90-day inhalation toxicity study of Terracess TF was performed to evaluate comparative inhalation toxicity of the disk shape with a fibrous shape that was previously evaluated. Four groups of 20 male and 15 female rats each were exposed to Terracess TF aerosols at concentrations of 0, 2, 10, or 50 mg/m(3) for 90 days. Ten male and 10 female rats per group were sacrificed at 90 days of exposure. After 90 days of exposure, 5 male rats per group were sacrificed at 3 wk of recovery period and 4-5 male rats per group or 5 female rats per group were sacrificed at 15 wk of recovery for lung clearance and histopathology. The mass median aerodynamic equivalent diameter (MMAED) of the aerosols of test materials ranged from 2.5 to 2.9 microm. There were no test-substance-related adverse effects on clinical observations. At the end of the 90-day exposure, a slight increase in lung-to-body weight ratios was observed at 50 mg/m(3) in male but not in female rats. However, lung weights were within normal limits after 3- or 15-wk recovery periods. Microscopically, inhaled Terracess TF particles were mostly phagocytized by free alveolar macrophages (AMs) in the alveolar airspaces and alveolar walls maintained normal structure at 2 and 10 mg/m(3). At 50 mg/m(3), some alveoli were distended and filled with aggregates of particle-laden AMs. The alveolar walls showed slight type II pneumocyte hyperplasia, but neither proliferative inflammation nor alveolar fibrosis was present at 50 mg/m(3). The clearance half-times for Terracess TF were estimated to be in the order of 6 to 9 mo for the 50-mg/m(3) group and 2 to 3 mo for the 10- and 2-mg/m(3) groups. The lung responses and lung clearance rate were comparable to those of "nuisance" type dusts at these concentrations. Based on interpretation that aggregated particle-laden AMs in alveoli was considered to be an early histopathological sign of lung overloading, an effect level was considered to be 50 mg/m(3) and no-observedadverse- effect level (NOAEL) was 10 mg/m(3). This experiment clearly demonstrated that particle morphology was considered to be an important factor to determine inhaled particle toxicity.


Subject(s)
Lung/drug effects , Minerals/toxicity , Titanium/toxicity , Aerosols , Animals , Female , Inhalation Exposure , Lung/pathology , Macrophages, Alveolar/drug effects , Macrophages, Alveolar/physiology , Male , Metabolic Clearance Rate , Minerals/pharmacokinetics , Organ Size , Particle Size , Phagocytosis/drug effects , Phagocytosis/physiology , Rats , Recovery of Function , Titanium/pharmacokinetics
9.
Food Chem Toxicol ; 47(9): 2269-80, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19524635

ABSTRACT

This 13-week feeding study conducted in Sprague-Dawley rats evaluated the potential health effects from long-term consumption of a rodent diet formulated with grain from genetically modified (GM), herbicide-tolerant maize DP-Ø9814Ø-6 (98140; trade name Optimum GAT (Optimum GAT is a registered trademark of Pioneer Hi-Bred)). Metabolic inactivation of the herbicidal active ingredient glyphosate was conferred by genomic integration and expression of a gene-shuffled acetylase coding sequence, gat4621, from Bacillus licheniformis; tolerance to acetolactate synthase (ALS) inhibiting herbicides was conferred by overexpression of a modified allele (zm-hra) of the endogenous maize ALS enzyme that is resilient to inactivation. Milled maize grain from untreated (98140) and herbicide-treated (98140+Gly/SU) plants, the conventional non-transgenic, near-isogenic control (091), and three commercial non-transgenic reference hybrids (33J56, 33P66, and 33R77) was substituted at concentrations of 35-38% w/w into a common rodent chow formula (PMI) Nutrition International, LLC Certified Rodent LabDiet 5002) and fed to rats (12/sex/group) for at least 91 consecutive days. Compared with rats fed diets containing grain from the conventional near-isogenic control maize, no adverse effects were observed in rats fed diets containing grain from 98140 or 98140+Gly/SU maize with respect to standard nutritional performance metrics and OECD 408-compliant toxicological response variables [OECD, 1998. Section 4 (Part 408), Health Effects: Repeated Dose 90-Day Oral Toxicity Study in Rodents, Guideline for the Testing of Chemicals. Organisation of Economic Co-operation and Development, Paris, France]. These results support the comparative safety and nutritional value of maize grain from genetically modified Optimum GAT and conventional, non-transgenic hybrid field corn.


Subject(s)
Animal Feed/toxicity , Drug Tolerance/genetics , Plants, Genetically Modified/toxicity , Toxicity Tests , Zea mays , Animal Nutritional Physiological Phenomena , Animals , Behavior, Animal/drug effects , Blood Chemical Analysis , Body Weight/drug effects , Eating/drug effects , Eye/drug effects , Female , Hematologic Tests , Male , Muscle Strength/drug effects , Nervous System/drug effects , Plants, Genetically Modified/chemistry , Plants, Genetically Modified/genetics , Rats , Rats, Sprague-Dawley , Zea mays/genetics , Zea mays/metabolism , Zea mays/toxicity
10.
Food Chem Toxicol ; 46(12): 3808-17, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18952136

ABSTRACT

DP-3Ø5423-1 (305423) is a genetically-modified (GM) soybean that was produced by biolistic insertion of a gm-fad2-1 gene fragment and the gm-hra gene into the germline of soybean seeds. The gm-fad2-1 gene fragment cosuppresses expression of the endogenous FAD2-1 gene encoding the seed-specific omega-6 fatty acid desaturase resulting in higher concentrations of oleic acid (18:1) relative to linoleic acid (18:2). The gm-hra gene encoding a modified acetolactate synthase (ALS) enzyme was used as a selectable marker. In the current study, processed fractions (meal, hulls, and oil) from 305423 soybeans, non-GM soybeans with a similar genetic background (near isoline control) and three commercially-available non-GM varieties were used to formulate diets that were nutritionally comparable to PMI Certified Rodent LabDiet 5002. Diets were fed to young adult Crl:CD(SD) rats (12/sex/group) for approximately 90 days. Compared with rats fed the non-GM control diet, no biologically relevant differences were observed in rats fed the 305423 diet with respect to body weight/gain, food consumption/efficiency, mortality, clinical signs of toxicity, or ophthalmological observations. No test diet-related effects were observed on neurobehavioral assessments, organ weights, or clinical or anatomic pathology. These results demonstrated that 305423 soybeans are as safe and wholesome as non-GM soybeans.


Subject(s)
Glycine max/chemistry , Glycine max/toxicity , Oleic Acid/toxicity , Animals , Behavior, Animal/drug effects , Blood Cell Count , Blood Chemical Analysis , Blood Coagulation/drug effects , Body Weight/drug effects , Diet , Eating/drug effects , Eye/pathology , Female , Male , Oleic Acid/analysis , Plants, Genetically Modified , Rats , Rats, Sprague-Dawley , Glycine max/genetics
11.
Toxicol Sci ; 105(1): 86-96, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18559402

ABSTRACT

Repeated high doses of ammonium perfluorooctanoate (APFO) have been reported to affect immune system function in mice. To examine dose-response characteristics in both rats and mice, male CD rats and CD-1 mice were dosed by oral gavage with 0.3-30 mg/kg/day of linear APFO for 29 days. Anti-sheep red blood cell (SRBC) IgM levels, clinical signs, body weights, selected hematology, and lipid parameters, liver weights, spleen, and thymus weights and cell number, selected histopathology, and serum corticosterone concentrations were evaluated. In rats, linear APFO had no effect on production of anti-SRBC antibodies. Ten and 30 mg/kg/day resulted in systemic toxicity as evidenced by decreases in body weight gain to 74 and 37%, and increases in serum corticosterone levels to 135 and 196% of control, respectively. In mice dosed with 10 and 30 mg/kg/day, marked systemic toxicity and stress were observed, as evidenced by a loss in body weight of 3.8 and 6.6 g, respectively (despite a tripling of liver weight), approximately 230% increase in serum corticosterone, and increases in absolute numbers of peripheral blood neutrophils and monocytes with an accompanying decrease in absolute lymphocyte numbers. Immune-related findings at 10 and 30 mg/kg/day that likely represent secondary responses to the systemic toxicity and stress observed at these doses include: decreased IgM antibody production at 10 (20% suppression) and 30 mg/kg/day (28% suppression); decreased spleen and thymus weights and cell numbers; microscopic depletion/atrophy of lymphoid tissue at 10 (thymus) and 30 mg/kg/day (spleen). In summary, no immune-related changes occurred in rats, even at doses causing systemic toxicity. In mice, immune-related changes occurred only at doses causing significant and profound systemic toxicity and stress.


Subject(s)
Caprylates/toxicity , Fluorocarbons/toxicity , Immune System/drug effects , Animals , Blood Cell Count , Body Weight/drug effects , Corticosterone/blood , Dose-Response Relationship, Drug , Immunoglobulin M/biosynthesis , Lipids/blood , Liver/drug effects , Liver/pathology , Male , Mice , Mice, Inbred ICR , No-Observed-Adverse-Effect Level , Organ Size/drug effects , PPAR alpha/physiology , Rats , Rats, Sprague-Dawley , Spleen/drug effects , Spleen/pathology , Thymus Gland/drug effects , Thymus Gland/pathology
12.
Food Chem Toxicol ; 46(6): 2201-13, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18403083

ABSTRACT

Optimum GAT1 soybean is a genetically modified (GM) soybean containing event DP-356Ø43-5 (356043) that was produced by integration of the coding sequences of the GAT4601 and GM-HRA proteins. In planta expression of these proteins confers tolerance to glyphosate and sulfonylurea/imidazolinone herbicides, respectively. This paper reports the results from a subchronic rat feeding study conducted with 356043 soybeans. Dehulled/defatted toasted meal and toasted ground hulls were prepared from soybeans from untreated plants (356043), herbicide-treated plants (356043+Gly/SU), non-transgenic isoline control (091), and three commercial non-transgenic reference varieties (93B86, 93B15, and 93M40). Individual diets conforming to standard certified rodent chow formulation (Purina Rodent LabDiet) 5002) were prepared with 20% meal (w/w) and 1.5% hulls (w/w). Diets were fed to young adult Sprague-Dawley rats (12/sex/group) for at least 93 days. Compared with rats fed the isoline control or conventional reference diets, no biologically-relevant, adverse effects were observed in rats fed diets containing 356043 or 356043+Gly/SU soybean with respect to body weight/gain, food consumption/efficiency, clinical signs, mortality, ophthalmology, neurobehavioral assessments (sensory response, grip strength, motor activity), clinical pathology (hematology, coagulation, serum chemistry, urinalysis), organ weights, and gross and microscopic pathology. The results from this study indicate that 356043 soybeans are as safe and nutritious as conventional non-GM soybeans.


Subject(s)
Glycine max/genetics , Glycine max/toxicity , Herbicides/toxicity , Plants, Genetically Modified/genetics , Plants, Genetically Modified/toxicity , Animals , Behavior, Animal/drug effects , Blood Cell Count , Blood Chemical Analysis , Blood Coagulation/drug effects , Body Weight/drug effects , Diet , Eating/drug effects , Eye Diseases/chemically induced , Eye Diseases/pathology , Female , Male , Motor Activity/drug effects , Organ Size/drug effects , Psychomotor Performance/drug effects , Rats , Rats, Sprague-Dawley , Urinalysis
13.
In Vitro Cell Dev Biol Anim ; 43(10): 344-51, 2007.
Article in English | MEDLINE | ID: mdl-17934781

ABSTRACT

Species identification of cell lines and detection of cross-contamination are crucial for scientific research accuracy and reproducibility. Whereas short tandem repeat profiling offers a solution for a limited number of species, primarily human and mouse, the standard method for species identification of cell lines is enzyme polymorphism. Isoezymology, however, has its own drawbacks; it is cumbersome and the data interpretation is often difficult. Furthermore, the detection sensitivity for cross-contamination is low; it requires large amounts of the contaminant present and cross-contamination within closely related species may go undetected. In this paper, we describe a two-pronged molecular approach that addresses these issues by targeting the mitochondrial genome. First, we developed a multiplex PCR-based assay to rapidly identify the most common cell culture species and quickly detect cross-contaminations among these species. Second, for speciation and identification of a wider variety of cell lines, we amplified and sequenced a 648-bp region, often described as the "barcode region" by using a universal primer mix targeted at conserved sequences of the cytochrome C oxidase I gene (COI). This method was challenged with a panel of 67 cell lines from 45 diverse species. Implementation of these assays will accurately determine the species of cell lines and will reduce the problems of misidentification and cross-contamination that plague research efforts.


Subject(s)
Cell Culture Techniques/methods , Animals , Electron Transport Complex IV/metabolism , Humans , K562 Cells , Phylogeny , Protein Subunits/metabolism , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...